Formulation and In vitro/In vivo evaluation of esomeprazole enteric coated minitablets

Hatlebakk, 2003, Review article: gastric acidity – comparison of esomeprazole with other proton pump inhibitors, Aliment. Pharmacol. Ther., 17, 10, 10.1046/j.1365-2036.17.s1.3.x Moayyedi, 2006, Gastro-oesophageal reflux disease, Lancet, 367, 2086, 10.1016/S0140-6736(06)68932-0 Kalaitzakis, 2007, A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD), Ther. Clin. Risk Manag., 3, 653 Lind, 2000, Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease, Aliment. Pharmacol. Ther., 14, 861, 10.1046/j.1365-2036.2000.00813.x Wilder-Smith, 2000, Esomeprazole 40 mg provides more effective acid control than pantoprazole (P) 40 mg, Gastroenter, 118, A22, 10.1016/S0016-5085(00)82157-5 Belo, 2000, Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes, Drug Metab. Dispos., 28, 966 Mark, 2007, Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole, Br. J. Clin. Pharmacol., 64, 386, 10.1111/j.1365-2125.2007.02889.x Nexium side effects". Drug information online. Drugs.com. Retrieved 2015. Nexium Highlights of prescribing information, Astrazeneca Pharmaceutical LP, 2014. Mangesh, 2010, MUPS tablets – a brief review, Int. J. PharmTech. Res., 2, 847 Mounika, 2014, Pharmaceutical mini tablets, its advantages and different enteric coating processes, World J. Pharm. Pharm. Sci., 4, 523 Lindberg, 2003, Review article: esomeprazole — enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion, Aliment. Pharmacol. Ther., 17, 481, 10.1046/j.1365-2036.2003.01481.x Bodmeier, 1997, Tableting of coated pellets: review article, Eur. J. Pharm. Biopharm., 43, 1, 10.1016/S0939-6411(96)00028-8 Sirisha, 2012, Multiple unit pellet systems: a review, Int. J. Pharm., 2, 419 Mounika, 2015, Pharmaceutical mini tablets, its advantages and different enteric coating processes, World J. Pharm. Pharm. Sci., 4, 523 Keerthi, 2014, Pharmaceutical mini-tablets, its advantages, formulation possibilities and general evaluation aspects: a review, Int. J. Pharm. Sci. Rev. Res., 28, 214 Ranjith, 2015, Pharmaceutical mini tablets, Int. J. Pharm. Tech. Res., 7, 507 Kaniwa, 1988, Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans, J. Pharmacobio-Dynamics, 11, 571, 10.1248/bpb1978.11.571 Kaniwa, 1988, Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates, J. Pharmacobio-Dynamics, 11, 563, 10.1248/bpb1978.11.563 Sugito, 1992, Gastric emptying rate of drug preparations. III. Effects of size of enteric micro-capsules with mean diameters ranging from 0.1 to 1.1 mm in man, Chem. Pharm. Bull., 40, 3343, 10.1248/cpb.40.3343 Schwizer, 2006, Magnetic resonance imaging for the assessment of gastrointestinal function, J. Gastro, 41, 1245 G.A. Digenis, The in vivo behavior of multiparticulate versus single unit dose formulations, CAPSUGEL’s Symposium in Seoul, 1990. Mohammed, 2012 Bharate, 2010, Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review, J. Excip. Food Chem., 1, 1 Ankalu, 2013, Development of enteric coated pantoprazole tablets with an aqueous based polymer, Int. J. Chem. Tech. Res., 5, 2394 International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonized Tripartite Guideline. Guidelines for Good Clinical Practice. May 1996. Guidance for Industry: FDA Bioanalytical Method Validation Guidelines US Dept. of Health and Human Services, Food and Drug Administration (FDA), Centre for Drug Evaluation and Research (Cder), May 2001. 1998 Costa, 2001, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci., 13, 123, 10.1016/S0928-0987(01)00095-1 Mady, 2014, Studying the effect of dispersed drug crystal in the organic phase on the encapsulation by solvent evaporation technique (3) Independent models as tools for studying the drug release profiles, World J. Pharm. Sci., 2, 409 Zajicek, 2012 Hlomb, 2014, Interaction between fed gastric media (Ensure Plus) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus, Int. J. Pharm., 461, 419, 10.1016/j.ijpharm.2013.12.003 Klein, 2010, The use of biorelevant dissolution media to forecast the in vivo performance of a drug, AAPS J., 12, 10.1208/s12248-010-9203-3 Haidar, 2008, Bioequivalence approaches for highly variable drugs and drug products, Pharm. Res., 25, 237, 10.1007/s11095-007-9434-x 2006 Tothfalusi, 2012, Sample sizes for designing bioequivalence studies for highly variable drugs, J. Pharm. Pharm. Sci., 15, 73